Skip to content
Disclosery

ORBIMED ADVISORS LLC: CGON position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on CGON, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 972,800 CGON shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 972,800 shares
    Change vs previous 13F +24,533 shares

    1.31% of the 13F portfolio, value $69,117,440.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 948,267 shares
    Change vs previous 13F -568,283 shares

    1.4% of the 13F portfolio, value $64,178,711.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,516,550 shares
    Change vs previous 13F -210,300 shares

    1.29% of the 13F portfolio, value $62,967,156.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,726,850 shares
    Change vs previous 13F -151,000 shares

    1.67% of the 13F portfolio, value $69,557,518.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,877,850 shares
    Change vs previous 13F -594,144 shares

    1.23% of the 13F portfolio, value $48,824,100.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 2,471,994 shares
    Change vs previous 13F +1,040,880 shares

    1.45% of the 13F portfolio, value $60,539,133.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,431,114 shares
    Change vs previous 13F +740,000 shares

    0.85% of the 13F portfolio, value $41,044,350.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 691,114 shares
    Change vs previous 13F not available

    0.48% of the 13F portfolio, value $26,075,731.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).